The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12407
Abstract: In dogs, inflammatory mammary carcinoma is a clinicopathological entity characterized by rapid progression and aggressive behavior from onset of disease. Reported median survival time is short, with no effective treatment options. The aims of this… read more here.
Keywords: radiation therapy; inflammatory mammary; time; therapy ... See more keywords
Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0267648
Abstract: Inflammatory mammary carcinoma (IMC), a neoplasia affecting women and female dogs, is considered an aggressive cancer with high metastatic potential and a low survival rate. Studies focused on the tumour microenvironment indicate that the aggressive… read more here.
Keywords: female dogs; response female; immune response; mammary carcinoma ... See more keywords
Leptin Modulates the Metastasis of Canine Inflammatory Mammary Adenocarcinoma Cells Through Downregulation of Lysosomal Protective Protein Cathepsin A (CTSA)
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21238963
Abstract: Canine malignant mammary gland tumors present with a poor prognosis due to metastasis to other organs, such as lung and lymph node metastases. Unlike in human studies where obesity has been shown to increase the… read more here.
Keywords: protein; canine inflammatory; inflammatory mammary; leptin ... See more keywords